Experience

Michael Tenta

    • Versartis $145 Million IPO 


    • FibroGen Closes Largest Biotech IPO in 12 Years 


    • Aduro Completes $137 Million IPO 


    • Eiger + Celladon Sign Merger Agreement 


    • Sonim Technologies – $39 Million IPO 


    • Zulily $253 Million Initial Public Offering 


    • CHC Group $310 Million Initial Public Offering and Refinancing Transactions 


    • Aquinox Pharmaceuticals Initial Public Offering 


    • Atreca - $125 Million IPO 


    • NGM Biopharmaceuticals - $107 Million IPO 


    • Triphase Accelerator Corporation in its Partnership and Option-to-acquire Arrangement with Celgene 


    • Personalis $155 Million IPO 


    • Rapt Therapeutics – $38 Million IPO 


    • Cytokinetics: $138 Million Convertible Senior Notes 


    • Dyne Therapeutics – $268 Million IPO 


    • Annexon – $251 Million IPO 


    • Sensei Biotherapeutics – $133 Million IPO